Cartesian Therapeutics, Inc.RNACNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Loading chart...

Alerts

Want to monitor RNAC?

Get notified when price crosses targets, volume spikes, or RSI hits oversold

Create free account to monitor RNAC

Key Statistics

About

selecta biosciences, inc. is a clinical-stage biopharmaceutical company that is focused on unlocking the full potential of biologic therapies by mitigating unwanted immune responses. selecta plans to combine its tolerogenic synthetic vaccine particles (svp™) to a range of biologics for rare and serious diseases that require new treatment options.

Sector

Professional, Scientific, and Technical Services

Industry

Research and Development in Biotechnology (except Nanobiotechnology)

CEO

Carsten Brunn

selectabio.com/ →

News

VRNS Investors Have Opportunity to Lead Varonis Systems, Inc. Securities Lawsuit

prnewswire.com

AT&T, ActiveProtective and JACS Collaborate to Enhance Senior Safety with New Tango Belt Connectivity Device

prnewswire.com

Who is Josh D'Amaro? Meet the frontrunner for Disney's next CEO

youtube.com

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance

Alerts

Key Statistics

About

News

Strategy Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?

3 Reasons Growth Investors Will Love AppFolio (APPF)

Global Payments (GPN) is an Incredible Growth Stock: 3 Reasons Why

Here is Why Growth Investors Should Buy Avnet (AVT) Now

3 Reasons Growth Investors Will Love Parker-Hannifin (PH)

3 Reasons Growth Investors Will Love Universal Health Services (UHS)

Here is Why Growth Investors Should Buy Epam (EPAM) Now

Hennes & Mauritz (HNNMY) is an Incredible Growth Stock: 3 Reasons Why

3 Reasons Why Growth Investors Shouldn't Overlook Tapestry (TPR)

Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why

Uber Prints Cash But The Market Complains (Q4 Earnings Preview)

Apple Bears Go Into Hibernation

Franklin Resources: Don't Mistake A Bull Market For An Improved Business

ARM to Post Q3 Earnings: Should the Stock Be in Your Portfolio Now?

Will GPU Expansion & Data Center Growth Boost IREN's Q2 Earnings?

Ermenegildo Zegna N.V. (ZGN) Q4 2025 Sales/Trading Call Transcript

Boeing: The Growth Is Just Starting

VRNS Investors Have Opportunity to Lead Varonis Systems, Inc. Securities Lawsuit

AT&T, ActiveProtective and JACS Collaborate to Enhance Senior Safety with New Tango Belt Connectivity Device

Who is Josh D'Amaro? Meet the frontrunner for Disney's next CEO

Explore More

Strategy Set to Report Q4 Earnings: Buy, Sell or Hold the Stock?

3 Reasons Growth Investors Will Love AppFolio (APPF)

Global Payments (GPN) is an Incredible Growth Stock: 3 Reasons Why

Here is Why Growth Investors Should Buy Avnet (AVT) Now

3 Reasons Growth Investors Will Love Parker-Hannifin (PH)

3 Reasons Growth Investors Will Love Universal Health Services (UHS)

Here is Why Growth Investors Should Buy Epam (EPAM) Now

Hennes & Mauritz (HNNMY) is an Incredible Growth Stock: 3 Reasons Why

3 Reasons Why Growth Investors Shouldn't Overlook Tapestry (TPR)

Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why

Uber Prints Cash But The Market Complains (Q4 Earnings Preview)

Apple Bears Go Into Hibernation

Franklin Resources: Don't Mistake A Bull Market For An Improved Business

ARM to Post Q3 Earnings: Should the Stock Be in Your Portfolio Now?

Will GPU Expansion & Data Center Growth Boost IREN's Q2 Earnings?

Ermenegildo Zegna N.V. (ZGN) Q4 2025 Sales/Trading Call Transcript

Boeing: The Growth Is Just Starting

VRNS Investors Have Opportunity to Lead Varonis Systems, Inc. Securities Lawsuit

AT&T, ActiveProtective and JACS Collaborate to Enhance Senior Safety with New Tango Belt Connectivity Device

Who is Josh D'Amaro? Meet the frontrunner for Disney's next CEO

Key Statistics